Trials / Completed
CompletedNCT04026685
Maternal Haemodynamic Changes After Crystalloid Co-loading and Phenylephrine Versus Phenylephrine Alone During Spinal Anaesthesia for Elective Caesarean Delivery
Maternal Haemodynamic Changes After Crystalloid Co-loading and Phenylephrine Versus Phenylephrine Alone During Spinal Anaesthesia for Elective Caesarean Delivery: a Double-blind, Randomised Controlled Trial Using the Non Invasive Cardiac Output Monitor StarlingTM SV.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Spinal anaesthesia is the anaesthetic technique of choice for elective caesarean delivery. Hypotension, a result of the decrease in systemic vascular resistance caused by spinal anaesthesia, is a frequent complication occurring in up to 80%. This study is to investigate fluid loading plus vasopressors to vasopressors alone to maintain stable maternal haemodynamics in elective caesarean delivery. The effect of the two methods (continuous prophylactic phenylephrine infusion with and without crystalloid co-loading) on maternal haemodynamics will be compared using the Starling SV Monitor. The Starling SV device is a non invasive cardiac output monitor (NICOM) which is certified and validated for the use in pregnancy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Phenylephrine infusion | continuous phenylephrine infusion started at a rate of 25mcg/min and titrated according to blood pressure |
| DRUG | Phenylephrine infusion and Ringer-Acetate bolus | continuous phenylephrine infusion started at a rate of 25mcg/min and titrated according to blood pressure plus crystalloid Ringer-Acetate co-loading bolus of 1000 mL |
Timeline
- Start date
- 2020-01-09
- Primary completion
- 2021-02-05
- Completion
- 2021-02-05
- First posted
- 2019-07-19
- Last updated
- 2021-02-17
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04026685. Inclusion in this directory is not an endorsement.